Average Co-Inventor Count = 4.83
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (71 from 669 patents)
2. Incyte Holdings Corporation (28 from 147 patents)
3. Prelude Therapeutics Incorporated (3 from 18 patents)
4. Incyte Incorporation (1 from 4 patents)
5. Prelude Therapeutics Incorporation (1 from 1 patent)
76 patents:
1. 12415809 - Pyrrolotriazine compounds as tam inhibitors
2. 12247020 - Bipyrazole derivatives as JAK inhibitors
3. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors
4. 11939340 - CDK inhibitors and their use as pharmaceuticals
5. 11905275 - Bipyrazole derivatives as JAK inhibitors
6. 11685744 - CDK inhibitors and their use as pharmaceuticals
7. 11622970 - BCL-2 inhibitors and their use as pharmaceuticals
8. 11591318 - Bipyrazole derivatives as JAK inhibitors
9. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors
10. 11229631 - Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
11. 11214573 - Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
12. 11130769 - Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
13. 11053215 - Heterocyclic compounds useful as Pim kinase inhibitors
14. 11001571 - Bipyrazole derivatives as JAK inhibitors
15. 10919901 - Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors